COMMUNIQUÉS West-GlobeNewswire

Summit Therapeutics to Participate in Upcoming Investor Conferences
09/02/2018
OXFORD, United Kingdom, Feb. 09, 2018 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ: SMMT ) (AIM:SUMM), the drug discovery and development company advancing therapies for rare diseases and infectious diseases, [...]
Bio-Path Holdings Announces 1-for-10 Reverse Stock Split
09/02/2018
HOUSTON, Feb. 09, 2018 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH ), a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio of [...]
Chembio Diagnostics Announces Pricing of its Public Offering of Common Stock
09/02/2018
MEDFORD, N.Y., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (NASDAQ: CEMI ) (“Chembio”), a leader in point-of-care diagnostic tests for infectious diseases, announced today the pricing of its previously [...]
Lotus Enters “Active Review” with Health Canada & Closes Cannabis Financing of $1 Million
09/02/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Feb. 09, 2018 (GLOBE NEWSWIRE) -- Lotus Ventures Inc (CSE:J) (the " Company ") announced today that [...]
pSivida to Present at the 2018 BIO CEO & Investor Conference
09/02/2018
WATERTOWN, Mass., Feb. 09, 2018 (GLOBE NEWSWIRE) -- pSivida Corp. (NASDAQ: PSDV ) (ASX:PVA), a leader in the development of sustained release drug products and technologies, announced today that Nancy Lurker, President [...]
AGTC Announces Financial Results and Business Update for the Quarter Ended December 31, 2017
09/02/2018
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (NASDAQ: AGTC ), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV [...]
Novo Nordisk A/S: Ozempic® (semaglutide) approved in the EU for the treatment of type 2 diabetes
09/02/2018
Bagsværd, Denmark, 9 February 2018 - Novo Nordisk today announced that the European Commission (EC) has granted marketing authorisation for Ozempic ® (semaglutide) for the treatment of adults with type 2 diabetes. [...]
Achillion to Present at the Leerink Partners 7th Annual Global Healthcare Conference
09/02/2018
NEW HAVEN, Conn., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN ) announced today that Milind Deshpande, Ph.D., President and Chief Executive Officer of Achillion, will participate in a [...]
ContraVir Pharmaceuticals to Present at BIO CEO & Investor Conference
09/02/2018
EDISON, N.J., Feb. 09, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced [...]
Calithera to Participate in Leerink Partners 7th Annual Global Healthcare Conference
09/02/2018
SOUTH SAN FRANCISCO, Calif., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA ), a clinical stage biotechnology company focused on the development of novel cancer therapeutics, today announced [...]
Ambu A/S: Articles of Association February 2018
09/02/2018
Articles of Association February 2018 Attachments: http://www.globenewswire.com/NewsRoom/AttachmentNg/ef9a3672-1646-4832-92e3-9680a37d2a9a
Ambu A/S: Capital increase in connection with exercise of warrants
09/02/2018
In December 2014, Ambu A/S issued 2,000,000 warrants, each warrant entitling the holder to subscribe for one Class B share with a nominal value of DKK 0.50. These warrants were issued to 22 employees with a vesting [...]
BioPorto and Roche Diagnostics sign a distribution agreement for NGAL
09/02/2018
BioPorto A/S (“BioPorto”) has entered into a global distribution agreement with Roche, under which BioPorto will deliver a neutrophil gelatinase-associated lipocalin (NGAL) test for use on Roche’s cobas c 501/c 502 [...]
CellaVision AB Year-end Bulletin 2017
09/02/2018
Stable quarter with continued strategic initiatives October 1 - December 31, 2017 Net sales increased by 5 percent to SEK 76.1 million (72.8). Organic growth was 6 % (14). Operating profit increased to SEK 21.7 million [...]
NeuroSearch A/S releasing Annual Report 2017
09/02/2018
Announcement no. 1-18 Page 1 of 2 Company announcement 9 February 2018 The full version of the Annual Report 2017 for NeuroSearch is available in the enclosed PDF file. In 2017, NeuroSearch (NEUR) realised an operating [...]
iTeos Therapeutics to Present New Preclinical Data from A2A Receptor Antagonist and Anti-TIGIT Antibody Programs at Molecular Medicine Tri-Conference
09/02/2018
iTeos Therapeutics to Present New Preclinical Data from A2A Receptor Antagonist and Anti-TIGIT Antibody Programs at Molecular Medicine Tri-Conference Two Phase 1 trials to start in 2018 for A 2A receptor antagonist and [...]
NeuroSearch A/S releasing Annual Report 2017
09/02/2018
Announcement no. 1-18 Page 1 of 2 Company announcement 9 February 2018 The full version of the Annual Report 2017 for NeuroSearch is available in the enclosed PDF file. In 2017, NeuroSearch (NEUR) realised an operating [...]
Outcome from DSMB Safety Review and Extension of TACTI-mel Phase I Clinical Trial
09/02/2018
SYDNEY, Australia, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX:IMM) (NASDAQ: IMMP ) (“Immutep” or the “Company”), announced today that the Database Safety Monitoring Board (“DSMB”) confirmed that the [...]
Pacific Biosciences Announces Outcome of First Phase of Patent Litigation Against Oxford Nanopore
09/02/2018
MENLO PARK, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB ) announced today that the U.S. International Trade Commission (the “ITC”) has terminated its investigation [...]

Pages